Pharmacological principles of antibiotic prescription in the critically ill

被引:81
作者
Pinder, M
Bellomo, R
Lipman, J
机构
[1] Royal Brisbane Hosp, Dept Intens Care, Brisbane, Qld 4029, Australia
[2] Intens Care Unit, Perth, WA, Australia
[3] Austin & Repatriat Med Ctr, Melbourne, Vic, Australia
关键词
antibiotics; intensive care unit; haemofiltration; acute renal failure; pharmacokinetics; pharmacodynamics;
D O I
10.1177/0310057X0203000203
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The goal of antimicrobial prescription is to achieve effective drug concentrations. Standard antimicrobial (losing regimens are based on research performed often decades ago and for the most part with patients who were not critically, ill. More recent insights into antibiotic activity (e.g. the importance of high peak/MIC ratios for aminoglycosides and time above MIC for beta-lactam antibiotics), drug pharmacokinetics (e.g. increased volume of distribution and altered clearances) and the pathogenesis of sepsis (e.g. third space losses and altered creatinine clearances have made re-evaluation of dosing regimens necessary for the critically ill. The inflammatory, response associated with sepsis results in a rapid decrease in serum albumin levels, large fluid shifts and third space losses, initially, with a high cardiac output. In turn these changes result in increased creatinine clearance and increased renal drug clearance. Unless these effects are offset by ensuing renal and/or hepatic impairment, with subsequent drug accumulation, antibiotic levels may, be too low for optimal efficacy. The institution of continuous renal replacement therapy separately, affects antibiotic clearances, and therefore dosing, even further. This article reviews relevant literature and offers principles for more effective and appropriate antibiotic dosing in the critically, ill, based oil the pharmacokinetic and pharmacodynamic principles of the main antibiotic groups (aminoglyosides, glycopeptides, beta-lactams, carbapenems and quinolones) and knowledge of the pathophysiology, of the inflammatory response syndrome. Finally, it also provides sonic guidance oil the basic principles of drug prescription for patients receiving continuous renal replacement therapy.
引用
收藏
页码:134 / 144
页数:11
相关论文
共 110 条
[41]   Intermittent and continuous ceftazidime infusion for critically ill trauma patients [J].
Hanes, SD ;
Wood, GC ;
Herring, V ;
Croce, MA ;
Fabian, TC ;
Pritchard, E ;
Boucher, BA .
AMERICAN JOURNAL OF SURGERY, 2000, 179 (06) :436-440
[42]   Single daily dosing of aminoglycosides in immunocompromised adults: A systematic review [J].
Hatala, R ;
Dinh, TT ;
Cook, DJ .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (05) :810-815
[43]   AMINOGLYCOSIDE DOSING IN BURN PATIENTS USING 1ST-DOSE PHARMACOKINETICS [J].
HOLLINGSED, TC ;
HARPER, DJ ;
JENNINGS, JP ;
MORRIS, SE ;
SAFFLE, JR .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1993, 35 (03) :394-398
[44]   Meropenem - A review of its use in patients in intensive care [J].
Hurst, M ;
Lamb, HM .
DRUGS, 2000, 59 (03) :653-680
[45]  
HUY PTB, 1988, J DRUG DEV S3, V1, P93
[46]   Pharmacodynamic modeling of risk factors for ciprofloxacin resistance in Pseudomonas aeruginosa [J].
Hyatt, JM ;
Schentag, JJ .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2000, 21 (01) :S9-S11
[47]   Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections [J].
James, JK ;
Palmer, SM ;
Levine, DP ;
Rybak, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) :696-700
[48]   Microdialysis -: A novel tool for clinical studies of anti-infective agents [J].
Joukhadar, C ;
Derendorf, H ;
Müller, M .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 57 (03) :211-219
[49]   Impaired target site penetration of β-lactams may account for therapeutic failure in patients with septic shock [J].
Joukhadar, C ;
Frossard, M ;
Mayer, BX ;
Brunner, M ;
Klein, N ;
Siostrzonek, P ;
Eichler, HG ;
Müller, M .
CRITICAL CARE MEDICINE, 2001, 29 (02) :385-391
[50]   Antimicrobial effects of continuous versus intermittent administration of carbapenem antibiotics in an in vitro dynamic model [J].
Keil, S ;
Wiedemann, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) :1215-1219